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ABSTRACT 
The current study describes the development of span-60 based organogels using sunflower oil 
(SO) as the apolar solvent. The organogels were analyzed for their stability. Subsequently, the 
stable organogels were characterized by gel-sol transition studies, microscopic analysis, opacity 
measurement, FTIR spectroscopy, XRD analysis, thermal analysis (using simultaneous TGA-
DTA and DSC) and pH measurement. Salicylic acid (SA), model drug, was incorporated within 
gels and their in vitro release behavior and antimicrobial efficiency against E. coli and B. subtilis 
were studied. To ascertain the biocompatibility of the gels, hemocompatibility tests were 
conducted. The stability tests indicated that the gels were inherently stable when stored below 
25°C. The gel-sol transition study indicated that as the concentration of the gelator was 
increased, there was a subsequent increase in the transition temperature. This was also confirmed 
by the instrumental thermal analysis studied. Microscopic analysis indicated that the solid fibers, 
formed by the clusters of needle-shaped gelator particles, form the backbone of the organogels 
structure. Opacity measurements suggested that the rate of gelation of the organogels is higher in 
organogels with higher gelator concentration. FTIR spectroscopy indicated the presence of 
hydrogen bonding in both blank and SA-loaded organogels. XRD studies showed that there was 
a change in the crystallinity of the samples and the change was dependent on the composition of 
the organogels. The pH of the organogels was found to be within the normal human skin pH 
range. The release studies indicated that the release of SA from the organogels occurred by 
Higuchian kinetics and were able to restrict the growth of E. coli and B. subtilis efficiently. The 
organogels were found to be hemocompatible in nature. Based on the results, the developed 
organogels may be tried as a drug carrier for transdermal and/or topical formulations. 
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1.1 Introduction 
 In the recent years, semisolid products have gained much importance in the food, 
nutraceutical, pharmaceutical and cosmetics industries. They have been used either as gels, 
lotions, creams, ointments and jellies. The method of preparation of these products is very 
tedious and complicated. Apart from this, there is a great concern associated with the long-term 
stability of most of these products due to which there is a reduced shelf-life of these products. 
The semisolid preparations having both solid and liquid components in its structures have been 
regarded as gels [1]. Gel-based semisolid products have been found to be more stable than other 
types [2]. In general, gel-based products may be categorized either as hydrogels or organogels, 
depending on the polarity of the liquid component. Hydrogels have water as the liquid 
component while organogels have apolar solvent (e.g. hexane, isopropyl myristate, sunflower oil 
and corn oil) as the liquid component. Amongst the gel-based products, the use of organogels 
based products is increasing, which may be attributed to the easy method of preparation and 
inherent long-term stability of these products [3]. Depending on the mechanism of the formation 
of the three dimensional skeleton, which help in immobilizing the apolar phase, the organogels 
are further categorized as fluid-filled structure and solid-fiber based organogels [4].Till recent 
past, most of the organogel based products were developed using non-biocompatible 
components. But with the advancement in the pharmaceutical, food, nutraceutical and cosmetics 
industries, various organogel based products are being developed using biocompatible 
components and have in use for human consumption [5-6].  
Sunflower oil (SO) obtained from dried kernels of Helianthus annuus is valued, healthy, and 
widely available commonly used edible oil. SO is rich in vitamin E. Presence of many anti-
oxidant and anti-carcinogenic species in SO has been reported [7-10]. 
In the present study, attempts were made to develop and characterize SO based organogels, using 
span-60 as the organogelator, for probable application in controlled drug delivery. 
1.2 Objective 
Development and characterization of span-60 based organogels for probable application in 
controlled drug delivery systems. 
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2.1 Introduction to gels 
 
 Gels are the semisolid viscoelastic systems. They are said to be the systems easy to 
identify then to define. We use many gels in our day to day life, such as soaps, shampoo, 
toothpaste, hair gel and cosmetics, as well as contact lenses and gel pens etc. Gel can either be 
natural gel or artificial or synthetic gel [2].  They may be considered as the intermediate between 
solid and liquid state of matter. Gels are considered to be at the interface between “complex 
fluids” and phase-separated states of matter [4].  Despite higher concentration of liquids in the 
composition of gels, they exhibit the properties of solids. Gels may also be considered as 
dispersions in which solid is a continuous phase and liquid is a discrete or discontinuous phase. 
 The gels can be dried and obtained in solid form. Depending upon the method of drying 
gels may be classified as either aerogel (formed by replacing the liquid phase with air), cryogel 
(obtained by freeze drying), and xerogel (obtained by using conventional drying method) (figure 
1) [2]. 
 There are 2 major types of gels, i) Hydrogels and ii) Organogels. The classification is 
based on nature of liquid, that the gel immobilizes. Hydrogels contains high amount of water in 
there composition. Whereas gels in which, the immobilized liquid is organic solvent are termed 
as organogels (figure 1). 
 Organogels are generally formed by immobilization of various liquids within 3-
dimensional network, formed by self assembly of fibers, formed of molecules called as gelators 
[4]. The network stops the flow of liquid by altering the surface tension of the liquid. It is the 
network of the gelator which gives gel a structure and stickiness. Interaction between gelator 
molecule to form aggregate and hence the fibers might be either covalent (chemical) or simply 
physical. Chemical gels are thermally irreversible whereas gels formed by weak non-covalent 
interactions (physical gels) are reversible [2]. 
 Due to involvement of complex mechanism behind bonding interactions and formation of 
network, it’s difficult to predict the ability of any molecule to gel the specific solvent. Hence 
research in the field of gels is largely based on serendipitous discoveries of gelators through 
blind screening. Many of the aspects of organogels are still poorly understood [4, 11]. 
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Figure 1: Classification of gels [2, 5] 
 
 A minimum concentration of gelator required to gel the solvent is known as Critical 
gelation concentration (CGC).  Below CGC concentration the resulting system exhibits flow 
properties and behaves as a liquid. 
 Stability of organogels depends on concentration of gelator, presence of aqueous phase, 
storage temperature, and properties of solvent. Organogels shows thermo-reversible behaviour. 
As temperature increases the interaction between gelator molecules decreases and organogels 
forms a liquid state, but as the temperature decreases the interactions between gelator molecules 
are restored and organogels obtain there original form[12]. 
 Organogels are reported to have many applications in Pharmaceuticals, nutraceuticals, 
food, cosmetics, and preservation of arts etc. 
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 Organogels do have some advantages over conventional drug delivery system, which 
includes longer shelf-life, no need of sophisticated instruments, less chances of batch to batch 
variations, ease of preparation and thermo-reversible nature of the organogels-based 
formulations [3]. The ability of the organogels to accommodate both hydrophilic and 
hydrophobic compounds within its structure has also widened the scope of use of organogels in 
various delivery systems. The research on biocompatible and edible organogels has added a new 
dimension in the food and pharmaceutical industries because of the easy preparation of the 
organogels [5]. The ability of the organogels to tailor the release of the solute molecules 
incorporated within its structure is keeping the researchers keen to develop new controlled drug 
delivery systems. Edible oil organogels have unique physical, functional and nutritional 
properties[6]. 
 Most of the organogels developed till-date consists of toxic solvents (like cyclohexanes, 
n-octane, kerosene etc) hence their human applications may create serious problems. 
Unfortunately, scarce toxicological information about many commonly used organogelators also 
restricts the use of organogels in drug delivery [5]. Hence more stress is being given on the 
development of biocompatible organogels which are based on generally regarded as safe 
(GRAS) materials. Edible oils can serve as better organic solvents for human use. 
 
2.2 Mechanism of gel formation 
 A gel can be divided into primary, secondary, and tertiary structure like a protein to 
understand the mechanism of gel formation. Primary structure (A0 to nm scale) is composed of 
unidirectional aggregation of gelator molecules. The secondary structure (nm to µm scale) is 
nothing but the morphology of the aggregates like micelles, vesicles, fibers, ribbons [13-14] or 
sheets. Whereas tertiary structure of a gel (µm to mm scale) involves the interaction of individual 
aggregates to form gel network [2]. 
 As stated earlier, organogels are formed by 3-dimensional network of intertwined fibers 
[11]. Fibers may be either fluid filled hollow fibers or solid fibers. The mechanism of formation 
of both is illustrated in figure 2 and figure 3 respectively. 
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Figure 2: Method of formation of organogels by fluid-filled fiber mechanism [5, 15] 
 
 
Figure 3: Method of formation of organogels by solid fiber mechanism [5, 15] 
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 Gels prepared by using LMW organogelator are stabilized by solid fibers. They are 
generally prepared by dissolving gelator in organic solvent at higher temperature and subsequent 
cooling at room temperature (figure 3). During cooling process three situations are possible i.e. a 
highly ordered aggregation giving rise to crystals, or a random aggregation resulting in an 
amorphous precipitate or an aggregation process intermediate between these two, which gives 
rise to a gel (figure 4). 
 
 
 
Figure 4: Various possible aggregation modes of gelator molecules [2] 
 
 The physical gels formed by LMW organogelators are stabilized by relatively weak inter-
chain interactions such as hydrogen bonding [16], van-der Waals forces, metal coordination [17], 
and π-π-stacking [11]. These organogelators forms fibers, strands, tapes or helix via 
unidimensional growth of the molecules [2, 5, 11]. 
 In case of cinnamic acid salt gelators it has been investigated that, prerequisite for the 
one-dimensional (1D) growth of the gel fibrils is mainly governed by the 1D hydrogen-bonded 
networks involving the ion pair. Whereas all the non-gelators show either two- (2D) or zero-
dimensional (0D) hydrogen bonded assemblies involving the ion pair [11]. 
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 Specialized type of heat set gel has also been developed using ß-CD and Para substituted 
aniline with Lithium chloride in N, N-Dimethylformamide. These gels are thermo-reversible in 
nature. They give clear solution at the room temperature but solidify and turn into gel on heating 
to higher temperature [18]. 
 
 
2.3 Classification of organogelators 
 
 Organogelators may be differentiated as one component organogelators and two 
component organogelators. Two component organogelators are dependent on one or more other 
compounds to gel the organic liquid. One component organogelator posses a ability to gel the 
organic solvent alone, without help or addition of any other component [2]. 
 Organogelators are broadly classified into 2 categories depending upon molecular weight 
of gelator [5] 
 
i) Low Molecular Weight (LMW) organogelators (LMWOG) and 
ii) Polymeric organogelators. 
 
2.3.1 Low Molecular Weight (LMW) organogelators 
 
 Many classes of low molecular weight compounds form stable and efficient gels with 
various organic solvents at low concentrations. They are characterized by their good solubility in 
organic solvents upon heating and smooth gelation at low concentration [16].  Gels formed using 
LMW organogelators are also termed as supra-molecular gels. In recent years they have got 
more attention due to great structural variety and diversity range they offer for a selector [2]. 
 Depending upon the major driving force involved in molecular aggregation LMW 
organogelators can be classified as either, i) Hydrogen bond based organogelators or ii) Non 
hydrogen bond based organogelators [11]. 
 
a) Amygdalin based organogelator 
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 Amygdalin has worked as good gelator for broad range of solvents such as nonpolar 
hexanes to polar aqueous solutions. These supermolecular hydrogels were demonstrated as, an 
enzyme triggered drug-delivery model for hydrophobic drugs [19]. 
 
b) Carbohydrate base organogelator 
 Trehalose, α-D-glucopyranosyl-(1-1)-ß-D-glucopyranoside is an alpha-linked 
disaccharide. It is obtained by fungi, plants, and invertebrate animals and it has been extensively 
used in the food, pharmaceutical, and cosmetic industries. It is used to gel many organic solvent 
at very low concentrations (0.04% w/v) [19]. 
 
c) Amino acid based organogelators 
 Simple cyclo(dipeptides)s are consisting of many amino acids and possesses remarkable 
gelation ability for many organic liquids such as, edible oils, glyceryl esters, alcohols, and 
aromatic molecules [16]. 
 
d) Cinnamic acid based organogelators 
 Organic salts prepared from dicyclohexylamine and substituted of non-substituted 
Cinnamic acid act as good gelators for organic liquid. They are capable of selective gelation of 
oil from oil/water mixture. Dicyclohexylammonium 4-chlorocinnamate, 3-chlorocinnamate, 4-
bromocinnamate, 3-bromocinnamate, 4-methylcinnamate are some of the examples [11]. 
 
e) Soyabean lecithin based organogelators 
 Soyabean lecithin was gelled by addition of water and extensively employed for the drug 
delivery [20]. 
 
2.3.2 Polymeric organogelators 
  
 Polymeric organogelator acts in similar way as that in case of LMW organogelators. 
Polymeric organogelators also immobilizes the organic solvent by formation of network 
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structure formed by physical interactions between polymer molecules. Polymers may be either 
linear, hyperbranched or star shaped polymer [5]. 
 Organogelators based on photochromic dihydroindolizine (DHI) system were developed 
by chemical synthesis. Controlled delivery of drug from these polymeric organogels can be 
achieved by using temperature, acidity, or light, as an external stimuli. These novel materials can 
be also used as photoreponsive materials and in nanotechnology [21].  
 Polymeric micelles made up of self assembly of amphiphillic molecules have been used 
in oral drug delivery. These micelles increases solubility of hydrophilic compounds in oil and 
hence can be used in preparation of anhydrous peptide products [22]. 
 Smart polymeric gels have been extensively used as a stimuli sensitive drug delivery in 
various biomedical applications like sensors and actuators [23]. They involve polymers that 
respond to change in common physiological triggers including change in pH, electrolyte 
concentration. Recent work has demonstrated an ability of the specific polymers to respond to 
antigen-antibody interaction, glucose, and enzymes [24]. Hence organogels made up of smart 
polymers is area with wide scope in biomedical applications. 
 Novel pH sensitive copolymer gelators have been prepared for controlled drug delivery. 
Dipyridamole was used as model drug and its controlled release rate was obtained by optimizing, 
polymer concentration, polymer molecular weight, temperature and pH of the solution [25]. 
 
Table 1: Some commonly used organogels 
Organogelator used Organic solvent gelled 
L-alanine derivatives 
Various pharmaceutical grade vegetable and 
synthetic oils [26] 
Cholesterol Liquid Paraffin [27] 
Sorbitan tristearate + Lecithin. Sunflower oil [28] 
Phytosterol + Oryzaznol Various Edible oils [29] 
TAG, DAG, MAG, FA, Waxes Various Edible oils [29] 
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12-Hydroxystearic acid (12-HAS). 
Soyabean oil or capric/caprylic triglyceride 
[30] 
ß-Cyclodextrin (ß-CD) 
Para substituted anilines (ps-An) 
Lithium Chloride in N, N- Dimethyl 
formamide [18] 
Triazine functionalized with α-amino 
acidic appendages. 
Haloalkanes, and aromatic solvents [31] 
 
 
2.4 Characterization of organogel 
 
Following various methods have been used for the characterization of organogels, 
 
Test for gelation/Determination of Critical Gelation concentration (CGC) 
 Inverted tube or inverted vial method is the most common method to confirm the 
gelation. In this method the weighed amount of organogelator is taken into a vial with weighed 
amount of organic solvent. The vial is then closed properly to create a pressure inside and so as 
to increase the boiling point of the liquid. The vial is carefully heated to a optimum temperature 
so as to melt its content completely. Then the vial is allowed to cool for sufficient time before 
inverting it. After inversion absence of flow indicates the formation of gel [2, 32]. 
 
Gel-Sol transition temperature (Tg) 
 Gel-sol transition temperature is the temperature below which gel doesn’t shows any 
distinct flow property. Gel loses its structural integrity at the temperatures above Tg. It is one of 
the important characteristic of organogel. It can be determined with either glass ball drop method 
[33], bubble motion [34], or by simple tube inversion method [32, 35]. Tg depends on physical 
and chemical properties of organogelator and solvent, as well as there interaction (either physical 
or chemical). It increases with the rise in the gelator concentration [11]. Thermal stability of 
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organogels can be accessed by plotting Tg against gelator concentration. Permanent gels formed 
by the chemical interaction between the large polymeric molecules don’t show gel-sol transition. 
 
Analytical methods 
 Analytical techniques like FT-IR, NMR Spectroscopy, X-Ray diffraction [13] analysis 
have been employed for the characterization of organogels. These methods provide valuable 
information regarding molecular interaction during aggregation of organogelator molecules. FT-
IR gives profitable information regarding Hydrogen bonding. The presence of intermolecular 
hydrogen bonding can be confirmed by NMR spectroscopy [16, 18]. 
 Shape of fibrillar network of organogelators can be studied by small-angle neutron 
scattering (SANS) technique [14]. 
 Information about morphology, specific interactions, internal mobility of the constituents, 
and molecular organization of organogels can be obtained by using, NMR measurement which 
involves magic angle spinning (MAS) in the solid-state NMR, spin relaxation times, nuclear 
overhauser enhancements (NOE), or multiple-quantum (MQ) spectroscopy, the pulse field 
gradient (PFG) technique and magnetic resonance imaging (MRI) [36]. 
 
2.5 Pharmaceutical applications of organogels 
  
 Skin acts as an effective barrier for most of the drugs except nitroglycerine scopolamine, 
nicotine, clonidine, fentanyl, estradiol, testosterone, Lidocaine, and oxybutinin. Hence topical 
formulation which will enhance permeability of drug and reduce the side effects is always a need 
of formulation [37]. Many organic substances like lipids act as a penetration enhancer and hence 
give an additional edge to the organogel formulations prepared from them. Organogels have been 
investigated successfully as a dermal pharmaceuticals [38]. 
 Severe gastric irritation caused due to oral administration of aceclofenac can be avoided 
by topical transdermal drug delivery [39]. It’s a choice of drug for osteoarthritis, rheumatoid 
arthritis and ankylosing spondylitis. Ethyl oleate based lecithin organogels (EO/Lecithin) were 
used for topical delivery of aceclofenac. They have found to be more effective than conventional 
hydrogels. The histopathological studies also proved the safety of the system [40]. Aceclofenac 
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was also formulated in the form of microemulsion for topical application [41]. Microemulsion 
have disadvantages that it need a large amount of surfactant and cosurfactants for stabilization of 
nanodroplets, poor viscosity and spreadabillity. On the other hand Lecithin organogels doesn’t 
require addition of any additional surfactant or penetration enhancer, as lecithin serves both the 
purposes. Organogels are having better viscosity and spreadability than microemulsion. 
 Soyabean lecithin organogels shows a faster rate of transdermal drug delivery of 
scopolamine and broxaterol as compared to conventional patches [42]. It has found to improve 
skin penetration of Diclofenac and Indomethacin when used with isopropyl palmitate [43]. 
Piroxicam an effective NSAID has been successfully incorporated into lecithin gels [44]. 
Ketorolac Tromethamine could also be incorporated into lecithin organogels in high amounts 
[45]. 
 Organogels have been extensively used as controlled drug delivery systems as 
summarized in table 2. 
 
Table 2: Organogels used in controlled or sustained delivery of drugs 
Organogelator 
used 
Organic 
solvent 
gelled 
Model drug used 
Pharmacological activity 
or category of the drug 
12-HAS 
(Hydroxystearic 
acid) 
Soybean 
oil 
Ibuprofen NSAID [46] 
Isostearyl alcohol 
Isostearyl 
alcohol, 
Propylene 
glycol 
Haloperidol 
Transdermal drug delivery 
[47-48] 
Stearyl acrylate 
Oleyl 
alcohol 
Indomethacin. NSAID [49] 
N-stearoyl L- Vegetable Leuprolide LH-hormone releasing 
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alanine (m)ethyl 
esters 
oils and 
Biocompa
tible 
hydrophili
c solvent 
hormone agonist in 
prostate 
cancer, endometriosis and 
precocious puberty [50] 
PG (Propylene 
glycol) or GP1 
(dibutyllauroylglut
amide) 
 
Terpene 
(Limonen
e) 
Haloperidol 
Anti-Psychotic and as a 
transdermal patch [47] 
Pluronic lecithin 
organogels 
Water Morphine 
topical analgesic for cancer 
pains [51] 
Modified tyrosine 
organogelator 
Safflower 
oil 
Rivastigmine 
Acetylcholinesterase 
Inhibitor in Alzheimer’s 
disease [52] 
Gelatin containing 
microemulsion 
based gel 
Isopropyl 
myristate 
and 
Tween 85 
Sodium Salicylate 
Topical Drug delivery 
through iontophoresis [53] 
Poly(N-
isopropylacrylami
de) 
Oleyl 
alchohol 
and water 
Indomethacin 
Temperature dependent 
pulsatile drug release 
system [54] 
Egg lecithin 
Span 40 
Cholesterol 
Alchohol 
Water 
Propranolol derivatives 
Non selective ß–blocker 
for hypertension [55] 
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Sodium 
deoxycholate 
Tween 80 
Water 
Lecithin 
Isopropyl 
palmitate 
Cycloocta
ne 
Scopolamine 
Broxaterol 
Estradiol 
Amino acids 
Peptides 
As a bronchodilator in 
asthma [42] 
Water 
Lecithin 
Iso-octane 
Propranolol Anti-hypertensive [56] 
Water Lecithin Tetra-benzamidine Anti-tumor [57] 
Water 
Soyabean 
lecithin 
Methyl nicotinate Topical application [58] 
Sorbitan 
monostearate 
Sweet 
almond 
oil, 
alkanes 
like 
hexane, 
decane, 
vegetable 
oils, etc. 
Propranolol, Cyclosporin 
antihypertensive and 
immunosuppressant [27] 
Lecithin Various 
organic 
Diclofenac Analgesic [59] 
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solvents 
Glyceryl fatty acid 
esters 
Mygliol® Ethinyl Estradiol, Piroxicam 
Orally bioactive estrogen 
[49], NSAID [60] 
Soya Lecithin 
Isopropyl 
Mysristate 
Ketorolac Tromethamine, 
cyclobenzaprine+ketoprofen
+diazepam 
NSAID [45] 
Anti-Psychotic [61] 
Soybean Lecithin 
Isopropyl 
palmitate 
Diclofenac, Indomethacin. Analgesic [43] 
bis-(4-
stearoylaminophen
yl) methane 
(BSAPM). 
Propylene 
carbonate 
Ferrocene, Ferricenium 
 
Anti-cancer [62] 
N-stearine-N0-
stearyl-L-
phenylalanine 
i-propyl 
myristate, 
Tween 80, 
propylene 
glycol and 
water 
Sodium Salicylate Anti-bacterial [63] 
1,3:2,4-di-O-
benzylidene-D-
Sorbitol (DBS) 
Propylene 
Glycol 
5-Flurouracil (5-FU) Antifungal [64] 
Span 60 
Hexadeca
ne 
- -[65] 
 
2.6 Miscellaneous applications of organogels 
 Smart gels which show novel response to photochemical, thermal or metallic response 
have been developed [66-67]. 
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 Development of biomaterials based soft materials will be a need of time [19]. Polymeric 
gels have found many industrial applications such as food, cosmetics [68], athletic shoes, 
preservation of arts [69], and chromatography. 
 LMWOGs have also been found to be promising structure-directing agents (templates) to 
make helical transition- metal oxides [70] and silica [71], to make microcellular materials [72], 
and in a CO2-based coating process [72] to make dye-sensitized solar cells [73]. 
 Selective water gelation property of some organogelators has been used in containment of 
oil spills. Organogelators can be useful in easy disposal of used edible oil in family kitchens [74]. 
 Extended unidirectional packing and long range intermolecular interactions make 
organogels a potential candidate in the research of molecular-based ferromagnetism, linear-
anisotropic energy transfer, charge carrier transporting, and light harvesting [75]. 
 Organogels has been used in the lubricant industry from 1970’s [4]. They are applied for 
the gelation of flammable solvents [76]. Organogels have been successfully used as a substitute 
for edible saturated trans fats [6]. 
 Extractant impregnated organogels have been successfully employed for the separation of 
metal ions from their aqueous solutions [77]. 
 The Triton-X100 based quaternary W/O microemulsion organogels consisting of Triton-
X100, water, 1-hexanol and n-hexane, were utilized in immobilization of lipase enzyme obtained 
from Candida rugosa [78]. Immobilization of Mucor Javanicus lipase enzyme in Gelatin based 
microemulsion gel formed with tween-85 and sodium bis(2-ethylhexyl) sulfosuccinate (AOT) 
was also carried out successfully [79]. 
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3. Materials and Methods 
3.1 Materials 
Span-60 (sorbitan monostearate) was purchased from Loba chemie, Mumbai, India. Salicylic 
acid (SA) was purchased from Sara fine chemicals, India. Edible refined sunflower oil (SO) was 
purchased from the local market. Dialysis tubing (MW cutoff: 60 kDa) was purchased from 
Himedia, Mumbai, India. All experimental studies were carried out using double distilled water. 
 
3.2 Methods 
 
3.2.1 Preparation of organogels 
Organogels of various compositions were prepared by dissolving specified amount of span-60 in 
SO, kept in a water bath maintained at 60oC and stirred at 500 rpm, until a homogeneous clear 
solution was obtained. The proportion of span-60 in SO was varied from 1- 25 % (w/w). The hot 
solution, so obtained, was allowed to cool down at room-temperature (RT) so as to allow gel 
formation. The samples were regarded as organogels, if upon cooling, the solution mixture failed 
to flow when the culture bottles were inverted [2, 40]. The minimum concentration (critical 
gelation concentration; CGC) of span-60 required for gelation of the apolar phase was 
determined. Drug loaded organogels were prepared by dispersing SA (a model drug) in SO. All 
the samples were kept at room-temperature for further analysis. 
 
3.2.2 Organoleptic evaluation 
Freshly prepared organogels samples were observed for their color, odour, taste, appearance and 
texture. 
 
3.2.3 Accelerated stability studies  
The accelerated stability test was done by thermo-cycling method. In short, freshly prepared 
organogel samples were subjected to repeated freezing-thawing cycles, by keeping them 
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alternatively at temperature -20°C and 60°C, respectively, for 15 minutes each. The study was 
continued up to 8 hours (i.e. 16 freezing- thawing cycles). Samples were analyzed visually after 
each 15 min for any destabilization indicator. A sample may be regarded as stable, if it can 
withstand at least 5 cycles of thermo-cycling. 
 
3.2.4 Stability studies on time scale 
Organogel samples were stored at ambient temperature, 5°C and 40°C and were observed at 
regular intervals for any signs of destabilization for a period of 9 months. 
 
3.2.5 Gel-Sol transition studies 
Organogels were incubated at various temperatures in the range of 30°C and 60°C in a constant 
temperature water bath. An increment of 5°C was made after 5 min incubation at previous 
temperature. Samples were analyzed by inverted test-tube method after each incubation period 
[2, 40]. The temperature at which samples started flowing was recorded as gel-sol transition 
temperature (Tg). 
 
3.2.6 Microscopic studies 
A compound optical microscope (Olympus CH20 i) was used for analyzing the microstructure of 
the organogels. Attempts were made to understand the mechanism of the organogel formation by 
varying the proportions of span-60 and analyzing their microstructures. 
 
3.2.7 Opacity measurement 
The organogels were heated at 70oC and were subsequently cooled down at room-temperature. 
The turbidity of the solution was measured using colorimeter (EI-D10 Digital Photo 
colorimeter). The change in turbidity of the solution was monitored at 400 nm using digital 
photo-colorimeter (EI Instruments India. model 312) either as a function of time or temperature.  
 
3.2.8 Fourier Transform Infra Red Spectroscopy 
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Infrared spectroscopy of the samples was carried out by using ATR-FTIR instrument (Alpha-E 
by Brucker, USA). The raw materials, representative blank organogel and representative SA-
loaded organogel were scanned in the range of 3500 cm-1 to 500 cm-1 to understand the 
interactions amongst the components of the organogel [80-81]. 
 
3.2.9 XRD analysis 
The samples were subjected to XRD analysis using Philips, XRD-PW 1700, Rockville, USA. 
Cu-Kα was used as the source, which was operating at 35 KV and 30 mA. Samples were scanned 
in the range of 10° to 50° 2θ at a rate of 2° 2θ per min.  
 
3.2.10 Thermal analysis 
Thermal properties of organogels were studied using simultaneous thermo-gravimetric analysis-
differentials thermal analysis (TA 60WS thermal analyzer, Shimadzu, Japan) and differential 
scanning calorimetry (DSC; STA 449C Jupiter, Netzsch, Germany). For simultaneous TGA-
DTA analysis, samples were heated from 27°C up to 250°C, at a rate of 6°C/min. For DSC 
analysis, the samples were subjected to heating in the temperature range of 29°C and 80°C, at a 
rate of 2.5°C/min. 
 
3.2.11 Antimicrobial evaluation 
Gram negative bacteria Escherichia Coli and gram positive bacteria Bacillus Subtilis were used 
to analyze the antimicrobial activity of the organogel. Solid nutrient agar was used as the media.  
1 ml of broth cell suspension containing 10-6 to10-7 cfu/ml was introduced into petriplates. 
Spread plate method was employed for the inoculation of the media. Wells of diameter 9 mm 
were created inside the media using a borer so as to accommodate 0.5 gm of organogel loaded 
with drug. Plates were then incubated at 37°C, for 24 h. The zone of inhibition was measured 
using scale after completion of incubation period. 
 
3.2.12 In vitro drug release studies 
A two-compartment cell was used for drug release study. Accurately weighed 1 g of organogel 
containing SA was introduced inside donor compartment. The compartments were separated by 
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the dialysis membrane (MW cutoff - 60 kDa, Himedia, Mumbai). Receptor compartment 
contained 50 ml of double distilled water (receptor fluid). Donor compartment was lowered so 
that the dialysis membrane was in contact with the receptor fluid, kept on stirring at 60 rpm, at 
37°C. For the first 1h, 50 ml of receptor fluid was completely replaced with fresh 50 ml water at 
an interval of 15 min. Subsequently, the replacement of the receptor fluid was done at an interval 
of 30 min up to 8 h. 5 ml of replaced fluid was kept for further analysis under UV visible 
spectrophotometer (Systronic 2203) at a wavelength of 277 nm and the rest was discarded. All 
the experiments were carried out in duplicates. Data obtained was analyzed by applying various 
drug release kinetic models, so as to find out best fit model. 
 
3.2.13 pH measurement  
The pH of organogel samples were detected by using digital ATC pH meter (EI instruments, 
model no- 132E). The pH of the organogels was measured by bringing the probe of the pH meter 
in contact with the samples. The pH of topical drug delivery preparations should lie in the range 
of 4.5-7 (skin pH), to avoid irritation to the skin [82]. 
 
3.2.14 Hemocompatibility test 
The hemocompatibility test was carried out to find out the extent of hemolysis in the presence of 
organogel samples. The organogels were put in dialysis bags, which were then immersed in 50 
ml of saline solution for 30 min. 0.5 ml of the dialyzate was used for the test. For this purpose, 
fresh goat’s blood is collected in the presence of sodium citrate (anticoagulant). 8 ml of citrated 
blood was diluted to 18 ml of saline solution.  0.5 ml of the diluted blood was taken in a 
centrifuge tube followed by the addition of the 0.5 ml of the test solution. Final volume was 
made up to 10 ml by addition of normal saline. For positive control, 0.5 ml of diluted blood was 
mixed with 0.5 ml of 0.1 N hydrochloric acid and subsequently diluted to 10 ml. For negative 
control, 0.5 ml of blood was diluted to 10 ml with saline solution. Centrifuge tubes were 
incubated at 37°C for 60 min. Tubes were subjected to centrifugation at 3000 rpm for 10 min to 
separate the cell content. Optical density (OD) of supernatant was determined at 545 nm using 
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spectrophotometer (Systronic 2203). The % hemolysis was calculated as per the following 
formula: 
% 100test Negative
positive Negative
OD OD
Hemolysis
OD OD
−
= ×
−  
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4.1 Preparation of organogels samples 
Span-60 was dissolved in SO, which was kept at 60°C and kept on stirring at 500 rpm, so as to 
obtain a clear homogenous solution. As the temperature of solution is lowered, span-60 starts 
precipitating out of the SO due to the change in the solubility parameter. The precipitated span-
60 crystals start growing in size as fibers. These fibers physically interacts with each other to 
form a three dimensional networked structure [11]. Clear solution firstly turns into cloudy 
solution and finally forms yellowish-white or white gels (figure 6). After the culture bottles were 
cooled to room-temperature, the bottles were inverted and observed for any flow. The samples 
were regarded as organogels, if they did not flow [2, 40]. The CGC of the organogelator was 
found to be 18 % (w/w). The organogels used for further analysis have been tabulated in table 3. 
 
 
Figure 5: Solution of 15 % (w/w) span-60 in SO (a) clear solution after heating at 60°C; (b) 
turbid suspension upon cooling and standing; (c) Upon further cooling and standing, 
suspension flowing on inverting the culture bottle. 
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Figure 6: Gelation process of organogel containing 18% (w/w) span-60 in SO; (a) clear 
solution after heating; (b) uniform, cloudy suspension upon cooling and standing; (c) 
opaque, semi-solid gel upon further standing. 
 
Table 3: Composition of the organogels used for further analysis 
Sample code 
 
Concentration of various components (w/w) 
Span-60 SO 
A 18 82 
B 19 81 
C 20 80 
D 21 79 
E 22 78 
F 23 77 
G 24 76 
H 25 75 
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4.2 Organoleptic evaluation 
The samples were found to be yellowish-white in color. Sample A lost its consistency when 
agitated with hand. As the concentration of the organogelator was increased, the consistency of 
the products increased. Incorporation of SA slightly improved the consistency of the sample A. 
All the samples were found to be oily to touch and were having gritty nature. The blank 
organogels were having a bland taste whereas SA-containing organogels were having slightly 
acidic taste. 
 
       
(a)               (b)              (c)              (d) 
       
(e)               (f)             (g)              (h) 
Figure 7: Span-60 based organogels; (a) A, (b) B, (c) C, (d) D, (e) E, (f) F, (g) G, and (h) H 
 
4.3 Accelerated stability studies  
Accelerated thermal stability test was carried out by thermo-cycling method. The method 
involves incubation of the samples alternatively at higher (60°C) and lower (-20°C) 
temperatures. The study helps in predicting the mechanism of destabilization of the samples 
either due to the change in the physio-chemical properties at the extreme conditions. At higher 
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temperatures, the chances of oxidative changes are predominant which may alter the stability of 
the samples whereas at lower temperatures, the formation of solidified structures may alter the 
physical interactions amongst the sample components responsible for the formation of the 
networked structures. This method only gives an prediction about the stability [83]. In general, it 
is expected that the samples should withstand at least 5 cycles of freeze-thawing process to be 
regarded as stable samples [84]. All the samples (mentioned in table 3) were found to be stable 
for more than 16 cycles without any signs of destabilization.  
 
4.4 Stability studies on time scale 
The duration of the time period for which a gel maintains its integrity, without any separation of 
the solid and the liquid phases, when stored in sealed vessels at a given environmental condition 
helps in predicting the shelf-life of the product at the given condition [15]. In order to determine 
the lifetime of the organogels under different environmental conditions, the samples were kept at 
5°C, 40°C and at ambient temperatures (25°C). The observations of the study are tabulated in 
table 4. The results indicate that when the samples are stored at 40°C, the samples get 
destabilized within 6 weeks time whereas the samples kept at 5°C and room-temperature were 
found to be stable during the experimental period of 32 weeks (8 months). The results suggests 
that the shelf-life of the samples may be prolonged if they are stored at lower temperatures and 
may be used as drug-delivery vehicles in the pharmaceutical industries [85]. 
Table 4: Results of stability studies on time scale 
 
Sample 
Destabilization time (weeks) 
Ambient  temperature At  5°C At 40°C 
A 32 32 4  
E 32 32 5  
F 32 32 6  
H 32 32 6  
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4.5 Gel-sol transition  
The organogels were subjected to increasing temperatures starting from 30°C to 60°C. An 
increment of 5°C was made after 5 min incubation at the previous temperature. The samples 
were considered to have undergone gel-sol transition when they started to flow when the culture 
bottles were inverted [86]. 
The rise in temperature results in the increase in surface active energy with a subsequent increase 
in the mobility of the self-assembled aggregates formed by the gelator molecules. With the 
further increase in temperature, the absorbed thermal energy interferes with the molecular 
interactions amongst the self-assembled aggregates, which are responsible for the three-
dimensional network structure of the organogels. The subsequent disruption of the networked 
structure causes the system to flow freely (figure 8). Gel-sol transition temperature of organogels 
was found to be dependent on gelator concentration. The concentration of span-60 in the range of 
17 % and 23 % (w/w) in the organogels did not affect the gel-to-sol transition temperature (table 
5). Gel-sol transition temperature (Tg) of the organogel containing 24 % and 25 % (w/w) span-
60 was found to be more than that of others. This may be attributed to the requirement of more 
heat energy required for the disruption of the more densely packed network structure as the 
gelator proportion is increased.  
 
Table 5: Results of gel-sol transition 
Sample  Gel-sol transition temperature 
A, B, C, D, E, F 55°C 
G, H 60°C 
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Figure 8: Gel-sol transition; (a) Sample A at 30º C and (b) Sample A at 55 º C. 
 
4.6 Microscopic studies 
The variation in the microstructure of the organogels was studied as the gelator proportion in the 
oil was changed (figure 9). The results showed the presence of needle shaped crystals of span-60 
in SO when 5 % (w/w) gelator concentration was used span-60 (figure 9). As the concentration 
of the gelator was increased, these clusters aggregated to form fiber-like structures. The density 
of these fiber-like structures increased with the increase in the gelator concentration. As the CGC 
was reached, these fiber-like structures were found to form networked skeleton which helped in 
the immobilization of the SO. 
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Figure 9: Micrographs of span-60/SO mixtures at RT. (a) 5 % (w/w), (b) 10 % (w/w), (c) 15 
% (w/w), (d) 18 % (w/w), (e) 20 % (w/w), (f) 22 % (w/w) 
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4.7 Opacity measurement 
The changes in the absorbance of the organogels as the hot solutions of span-60/SO were cooled 
at RT have been shown in figure 10. It was found that at the same temperature, the sample with 
higher concentration of span-60 showed a higher absorbance than that of the sample with lower 
concentration of the organogelator. As the concentration of the gelator was increased in the 
sample, the quicker the saturation in the OD was observed. This indicates that the rate of 
precipitation of the span-60 increases as the concentration of the span-60 is increased. This result 
supports the observation of relatively quick gelation of samples with higher concentration of 
span-60. Sol-gel transition was found out by linear curve fitting of the absorption points in the 
linear region (figure 10). The point of intersection of the linear curves was taken as the sol-gel 
transition. The sol-gel transition was found to be 58.59oC, 55.13oC, 55.09oC and 54.47oC for 
samples A, E, G and H, respectively.  
The change in the absorbance of the hot solutions as a function of cooling time has been shown 
in figure 11. The results indicate that as the gelator concentration was increased, the absorbance 
of the solution was higher at a particular instance of time. This suggests that as the solutions are 
cooled at room-temperature, the rate of precipitation of the gelator is higher in samples with 
higher proportions of organogelators. 
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Figure 10: The change in the absorbance of the hot solutions of span-60/SO as the same 
cooled down at RT w.r.t. temperature. 
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Figure 11: The change in the absorbance of the hot solutions of span-60/SO as the same 
cooled down at RT w.r.t. time. 
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4.8 FTIR analysis 
Sample A and AD were taken as the representative samples. Figure 12 shows the FTIR 
spectrogram of span-60, SO, sample A and sample AD. FTIR spectroscopy indicates the 
presence of molecular interactions amongst the components present in the sample. The spectra of 
the A and AD samples were found to be similar. SO also showed a similar spectra as that of 
sample A and AD except the absence of the broad peak in the range of 3,700 cm-1 to 3,100 cm-1. 
This suggests the presence of stretched hydrogen bonded O-H groups in the samples A and AD 
indicating the presence of intermolecular hydrogen bonds which play an important role in 
formation of solid fiber organogels [13]. Peaks observed for sample AD were more intense than 
that of sample A which might be attributed to the presence of SA within its structure. The 
characteristic functional groups stretches indicate the presence of alkane (3008 cm-1, and 2922 
cm-1), N-methyl (2853 cm-1), saturated ester (1743 cm-1) and C-O stretch (1160 cm-1) in the raw 
materials and the samples [81, 87]. 
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Figure 12: Graph showing results of FT-IR analysis; (a) span-60, (b) SO, (c) A, and (d) AD 
 
4.9 XRD analysis 
The A and H organogel samples were taken as the representative samples. The effect of 
incorporation of SA and thermo-cycling on the crystallinity of the samples was studied by XRD 
analysis. The XRD profiles have been shown in figure 13. The full widths at half maximum 
(FWHM) and area under the curve (AUC) for the analyzed samples have been tabulated in table 
6. 
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Figure 13: XRD data of the organogel samples; a) H and HD b) A and AD c) H and H-T 
and d) SA 
Table 6: Values of AUC and FWHM for XRD studies 
Sample  AUC  FWHM  Sample  AUC  FWHM  Sample  AUC  FWHM  
H  431.53  6.24  A  687.45  9.00  H  431.53  6.24  
HD  556.06  6.92  AD  532.82  6.72  H-T  473.16  6.24  
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The presence of a single broad peak at 20° 2θ for all the blank organogels and drug loaded 
organogels indicate amorphous dominant nature of the samples with low crystallinity. 
Crystallinity of organogels may be attributed to the presence of network structure made up of 
solid fibers of span-60 formed in SO. SA showed three sharp peaks at 10°, 18°  and 30° 2θ 
indicating its crystalline nature.  But as SA was incorporated in the gels no peaks corresponding 
to SA was found. This can be explained by the solubility of SA in the oil fraction of gels [88]. 
SA used in the composition of organogel got uniformly dissolved in the SO which is entrapped 
within the gelator network. Hence, the crystals of SA are not available responsible for the 
characteristic peaks. Incorporation of SA slightly decreased the crystalline nature of the sample 
H evident from the increased FWHM and AUC (table 6). On the other hand, the crystallinity of 
the sample A increased with the incorporation of the SA. This explains the improved consistency 
of the sample A as SA is incorporated. The XRD profile of the sample H indicated that there was 
not much change in the crystallinity of the samples even after accelerated thermal stability tests 
(sample HT). 
 
4.10 Thermal Analysis 
The simultaneous DTA-TGA thermogram profile of the sample A has been shown in figure 14. 
DTA thermogram showed a melting endotherm of sample A at 58.34ºC. A subsequent 
exothermic peak corresponding to weight loss, obtained from TGA thermogram, was observed at 
~196 °C. This might be attributed to release of heat energy due to the degradation of the sample 
components. 
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Figure 14: Simultaneous TGA-DTA thermogram of organogel A 
 
The samples H, A, HD and AD were subjected to thermal analysis, using a differential scanning 
calorimeter, in the temperature range of 29°C to 80°C. Characteristic endothermic peaks were 
observed in DSC thermograms of H, HD, A and AD. The results indicate that with the increase 
in the gelator concentration, there was a subsequent increase in the melting endotherm. The 
melting endotherm of sample AD was found to be higher than the sample A whereas the melting 
endotherm of sample HD was found to be lower than sample H, figure 15. This may be 
explained by the XRD results, which suggested that the crystallinity of the sample AD was 
higher than sample A and the crystallinity of sample HD was lower than sample H. In general, 
higher the crystallinity, higher is the melting temperature [89].  
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Figure 15: DSC thermogram of organogels; a) H and HD, b) A and AD 
 
4.11 Antimicrobial evaluation 
The sample A acted as a negative control whereas the sample AD was used as the test samples 
for the antimicrobial efficacy of the formulation against E. coli and B. subtilis. The zone of 
inhibition was measured after 24 h of incubation of the microbes in the presence of the 
organogels. The antimicrobial activity after the incubation period has been shown in figure 16 
and the results have been tabulated in table 7. The sample AD was able to inhibit the growth of 
both the microorganism even after 24 h in the neighborhood zone (table 7). On the other hand, 
the sample A did not show any zone of inhibition. This suggests that the antimicrobial activity of 
the sample AD is due to the SA present in the formulation. 
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Table 7: Results of Antimicrobial screening test. 
 
 
 
 
 
 
 
 
Figure 16: Effect of samples A and AD on the microbial growth; (a) B. subtilis, and (b) E. 
coli. T= Test (sample AD) and NC= negative control (sample A). 
 
4.12 In vitro drug release studies 
Release of drug from a formulation depends upon its solubility and partition coefficient in oil 
and water [45]. In vitro drug release study help predicting the drug release profile and drug 
release kinetics. This may help in correlating the drug activity when administered in the 
physiological system The type of release pattern from a formulations can be predicted by 
Bioactive agent 
Zone of inhibition (diameter; cm) 
E. coli Bacillus subtilis Control 
Salicylic Acid 1 % (w/w) 1.1 ± 0.2 1.1 ± 0.3 nil 
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applying various drug release kinetic models, e.g. zero order, first order, Higuchi, Hixon-
Crowell, Weibull, Korsemeyer-peppas etc. [90-92]. 
The release profiles of the drug from the organogels have been shown in figure 17 as a function 
of time. The amounts of drug release from the AD, DD, and HD samples were found to be 40 % 
(approx.), 38 % (approx.) and 36 % (approx.), respectively, at the end of 8 h.  This suggests that 
as the amount of gelator is increased there is subsequent reduction in the drug release rate. This 
indicates that drug release is dependent on the solid skeleton network formed by the gelator 
molecules [5, 93]. 
Table 8 shows the drug release rate constant (k) and coefficient of determination (r2) determined 
for different kinetic models of drug release. The release kinetics best-fit model indicated that the 
release of the drug from the organogels followed Higuchi Model kinetics (figure 17 and table 8), 
indicating that the organogels may be used as controlled delivery systems. Korsmeyer-Peppas 
model was used to figure out the fickian constant ‘n’. The n value was found to be in between 
0.5 and 0.7, suggesting that the release mechanism was a combination of both fickian and non-
fickian kinetics. 
It can be concluded from the above that the A, D and H samples may be used as a matrix for 
controlled release, which have been quite often associated with the solid fiber organogels [5, 93]. 
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Figure 17: CPR values for different compositions of the organogel samples as a function of 
time 
 
0 5 10 15 20 25
0
10
20
30
40
 AD
 DD
 HD
Cu
m
ul
at
iv
e %
 R
ele
as
e (
CP
R)
Square root of time
 
Figure 18: Higuchian-model kinetics for the different organogels samples; (a) AD, (b) DD, 
and (c) HD 
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Table 8: Kinetics of drug release 
 
Sample r2, k and n values for in vitro drug release kinetics 
 Zero Order First Order Higuchi Model Hixon-Crowell Model Weibull model Korsmeyer peppas Model 
 r2 K0 r2 K1 r2 kH r2 kHC r2 KW r2 n 
AD 0.922 0.001 0.0390 5.422E-4 0.998 1.914 0.019 8.598E-4 0.846 1.119 0.995 0.592 
DD 0.940 0.001 0.111 9.669E-4 0.997 1.844 0.110 8.691 E-4 0.868 1.131 0.996 0.602 
HD 0.949 0.001 0.045 5.898E-4 0.993 1.775 0.025 9.923E-4 0.895 1.147 0.988 0.619 
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4.13 pH measurement  
The pH values of the organogel samples were found to be in the range of 5.5 and 6.7 (table 9), 
which is in close to skin pH 4.5-7 [82, 94-97]. This indicates that the samples may not cause any 
irritation to the skin and hence can be used for topical applications. 
 
Table 9: pH values of organogel samples 
Sample Code pH 
A 5.90 ± 0.30 
B 5.83 ± 0.42 
C 6.50 ± 0.15 
D 6.70 ± 0.20 
E 5.50 ± 0.30 
F 5.70 ± 0.15 
G 6.30 ± 0.30 
H 6.10 ± 0.30 
 
4.14 Hemocompatibility test 
The %age hemolysis of goat RBCs was measured in the presence of the sample leachant and has 
been tabulated in table 10. The results suggested that all the organogel samples were highly 
hemocompatible (% hemolysis < 5 %) and may be regarded as biocompatible in nature [98]. 
Table 10: Results of the hemocompatibility test 
Sample  % Hemolysis 
A 0.85 
AD 1.25 
H 0.98 
HD 1.32 
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The study reports the successful development of span-60 and SO based organogel. Microscopic 
studies indicated that small needle-shaped clusters aggregated to form fibers, which underwent 
interaction amongst each other to form a networked structure. The networked structure helped in 
the immobilization of the SO. Stability studies indicated the stable nature of the developed 
organogels. The antimicrobial studies carried out using SA loaded samples suggested that the 
formulations may be used as antimicrobial organogels. In vitro studies indicated prolonged 
release of SA from the organogel matrix and the release of the SA from the organogel followed 
Higuchian kinetics. The pH of the organogels suggested that the organogels might be non-irritant 
in nature. The organogels were found to be biocompatible in nature. In short, the organogels 
developed may be tried as a matrix for controlled drug delivery. 
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